Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardunolizumab in Soft Tissue Sarcoma
NCT06114173Phase 1Unknown
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Nov 2022
- Primary completion
- Jun 2023
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label trial of cadonilimab in soft tissue sarcoma (STS), sponsored by Xiangya Hospital, Central South University. Status: unknown.
02
Drugs
cadonilimab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT06114173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06114173.